tradingkey.logo
tradingkey.logo

United-Guardian Inc

UG
View Detailed Chart
6.503USD
+0.253+4.06%
Market hours ETQuotes delayed by 15 min
29.89MMarket Cap
14.19P/E TTM

United-Guardian Inc

6.503
+0.253+4.06%
Intraday
1m
30m
1h
D
W
M
D

Today

+4.06%

5 Days

+3.89%

1 Month

-3.22%

6 Months

-14.65%

Year to Date

+5.58%

1 Year

-28.92%

View Detailed Chart

TradingKey Stock Score of United-Guardian Inc

Currency: USD Updated: 2026-03-27

Key Insights

United-Guardian Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 105 out of 157 in the Pharmaceuticals industry.Institutional ownership is very high.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

United-Guardian Inc's Score

Industry at a Glance

Industry Ranking
105 / 157
Overall Ranking
299 / 4542
Industry
Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

United-Guardian Inc Highlights

StrengthsRisks
United-Guardian, Inc. is a manufacturer of cosmetic ingredients, sexual wellness ingredients, pharmaceuticals, and medical lubricants. The Company’s product lines include the Lubrajel line of multifunctional hydrogel formulations, which are designed to provide sensory enhancement, lubrication, hydration, and texture to both personal care and medical products. Its four distinct product categories include cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. Its COSMOS line of products includes Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural, and Lubrajel Terra. Its medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. The Company’s pharmaceutical products include an FDA-approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial.
Growing
The company is in a growing phase, with the latest annual income totaling USD 10.55M.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 84.79%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 84.79%.
Fairly Valued
The company’s latest PE is 14.31, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 1.03M shares, decreasing 10.76% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 186.65K shares of this stock.

Analyst Rating

Based on 0 analysts
--
Current Rating
0.000
Target Price
0.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

United-Guardian Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

United-Guardian Inc Info

United-Guardian, Inc. is a manufacturer of cosmetic ingredients, sexual wellness ingredients, pharmaceuticals, and medical lubricants. The Company’s product lines include the Lubrajel line of multifunctional hydrogel formulations, which are designed to provide sensory enhancement, lubrication, hydration, and texture to both personal care and medical products. Its four distinct product categories include cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. Its COSMOS line of products includes Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural, and Lubrajel Terra. Its medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. The Company’s pharmaceutical products include an FDA-approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial.
Ticker SymbolUG
CompanyUnited-Guardian Inc
CEO
Websitehttps://u-g.com/
KeyAI